Ohcanbohtosat - Moore, Ellen

Efficacy of intralesional injection with PV-10 in combination with co-inhibitory blockade in a murine model of melanoma Dahkki Pilon-Thomas, Shari, Liu, Hao, Kodumudi, Krithika, Weber, Amy, Moore, Ellen, Sarnaik, Amod A

Viečča ollesdeavstta Viečča ollesdeavstta

Discordance between Viral Loads Determined by Roche COBAS AMPLICOR Human Immunodeficiency Virus Type 1 Monitor (Version 1.5) Standard and Ultrasensitive Assays Caused by Freezing P... Dahkki Salimnia, Hossein, Moore, Ellen C., Crane, Lawrence R., MacArthur, Rodger D., Fairfax, Marilynn R.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer Dahkki Toomey, Paul, Kodumudi, Krithika, Weber, Amy, Kuhn, Lisa, Moore, Ellen, Sarnaik, Amod A., Pilon-Thomas, Shari

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Established T-cell inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1–pathway blockade Dahkki Moore, Ellen, Clavijo, Paul E., Davis, Ruth, Cash, Harrison, Van Waes, Carter, Kim, Young, Allen, Clint

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Enhanced tumor control with combination mTOR and PD-L1 inhibition in syngeneic oral cavity cancers Dahkki Moore, Ellen C., Cash, Harrison A., Caruso, Andria M., Uppaluri, Ravindra, Hodge, James W., Van Waes, Carter, Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function Dahkki Clavijo, Paul E., Friedman, Jay, Robbins, Yvette, Moore, Ellen C., Smith, Ernest, Zauderer, Maurice, Evans, Elizabeth E., Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer Dahkki Morisada, Megan, Moore, Ellen C., Hodge, Rachel, Friedman, Jay, Cash, Harrison A., Hodge, James W., Mitchell, James B., Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma Dahkki Tran, Linda, Allen, Clint T., Xiao, Roy, Moore, Ellen, Davis, Ruth, Park, So-Jin, Spielbauer, Katie, Van Waes, Carter, Schmitt, Nicole C.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies Dahkki Friedman, Jay, Morisada, Megan, Sun, Lillian, Moore, Ellen C., Padget, Michelle, Hodge, James W., Schlom, Jeffrey, Gameiro, Sofia R., Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid derived suppressor cells with a selective inhibitor of PI3Kδ/γ Dahkki Davis, Ruth J., Moore, Ellen C., Clavijo, Paul E., Friedman, Jay, Cash, Harrison, Chen, Zhong, Silvin, Chris, Van Waes, Carter, Allen, Clint

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells Dahkki Clavijo, Paul E., Moore, Ellen C., Chen, Jianhong, Davis, Ruth J., Friedman, Jay, Kim, Young, Van Waes, Carter, Chen, Zhong, Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy Dahkki Sun, Lillian, Moore, Ellen, Berman, Rose, Clavijo, Paul E., Saleh, Anthony, Chen, Zhong, Van Waes, Carter, Davies, John, Friedman, Jay, Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation Dahkki Morisada, Megan, Clavijo, Paul E., Moore, Ellen, Sun, Lillian, Chamberlin, Michael, Van Waes, Carter, Hodge, James W., Mitchell, James B., Friedman, Jay, Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms Dahkki Moore, Ellen C., Sun, Lillian, Clavijo, Paul E., Friedman, Jay, Harford, Joe B., Saleh, Anthony D., Van Waes, Carter, Chang, Esther H., Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Alteration in the Gene Encoding Protein Tyrosine Phosphatase Nonreceptor Type 6 (PTPN6/SHP1) May Contribute to Neutrophilic Dermatoses Dahkki Nesterovitch, Andrew B., Gyorfy, Zsuzsa, Hoffman, Mark D., Moore, Ellen C., Elbuluk, Nada, Tryniszewska, Beata, Rauch, Tibor A., Simon, Melinda, Kang, Sewon, Fisher, Gary J., Mikecz, Katalin, Tharp, Michael D., Glant, Tibor T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor-antigen specific T cells Dahkki Friedman, Jay, Moore, Ellen C., Zolkind, Paul, Robbins, Yvette, Clavijo, Paul E., Sun, Lilian, Greene, Sarah, Morisada, Megan, Mydlarz, Wojciech, Schmitt, Nicole, Hodge, James, Schreiber, Hans, Van Waes, Carter, Uppaluri, Ravindra, Allen, Clint T.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta